Vanguard Group Inc Celcuity Inc. Call Options Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CELC
# of Institutions
107Shares Held
30.3MCall Options Held
30.8KPut Options Held
152K-
Bvf Inc San Francisco, CA3.47MShares$45.7 Million1.64% of portfolio
-
Perceptive Advisors LLC New York, NY2.36MShares$31.2 Million0.92% of portfolio
-
Baker Bros. Advisors LP New York, NY1.87MShares$24.7 Million0.3% of portfolio
-
Eventide Asset Management, LLC Boston, MA1.54MShares$20.2 Million0.4% of portfolio
-
Commodore Capital LP New York, NY1.52MShares$20.1 Million1.93% of portfolio
About Celcuity Inc.
- Ticker CELC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,941,300
- Market Cap $197M
- Description
- Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...